CN103816493A - Traditional Chinese medicine composition for treating non-consolidation of kidney-qi - Google Patents
Traditional Chinese medicine composition for treating non-consolidation of kidney-qi Download PDFInfo
- Publication number
- CN103816493A CN103816493A CN201410107019.6A CN201410107019A CN103816493A CN 103816493 A CN103816493 A CN 103816493A CN 201410107019 A CN201410107019 A CN 201410107019A CN 103816493 A CN103816493 A CN 103816493A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- chinese medicine
- radix
- kidney
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 238000007596 consolidation process Methods 0.000 title abstract 3
- 210000003734 kidney Anatomy 0.000 claims abstract description 31
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 244000268590 Euryale ferox Species 0.000 claims abstract description 9
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 9
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 20
- 239000002994 raw material Substances 0.000 claims description 11
- 241000208340 Araliaceae Species 0.000 claims description 10
- 241000756943 Codonopsis Species 0.000 claims description 10
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 230000027939 micturition Effects 0.000 abstract description 10
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000004087 circulation Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000010428 Alpinia katsumadae Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 208000008967 Enuresis Diseases 0.000 description 3
- 206010041497 Spermatorrhoea Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010036596 premature ejaculation Diseases 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 206010011878 Deafness Diseases 0.000 description 2
- 206010013886 Dysaesthesia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating non-consolidation of kidney-qi. The traditional Chinese medicine composition is prepared from the following raw traditional Chinese medicines in parts by weight: 10-30 parts of white atractylodes rhizome, 5-25 parts of Chinese yam, 5-20 parts of radix curcumae longae, 5-25 parts of pericarpium citri reticulatae, 5-20 parts of ginseng, 5-25 parts of angelica sinensis, 5-20 parts of coptis chinensis, 5-25 parts of codonopsis pilosula, 5-20 parts of alpinia katsumadai, 5-25 parts of fructus rubi, 5-20 parts of fructus amomi, 5-25 parts of cherokee rose fruit, 5-20 parts of ligusticum wallichii, 5-25 parts of gorgon fruit, 10-40 parts of radix salviae miltiorrhizae, 5-25 parts of rhizoma cyperi, 10-30 parts of yam rhizome, 5-25 parts of poria and 5-15 parts of liquorice. The traditional Chinese medicine composition disclosed by the invention has the effects of nourishing the kidneys, promoting circulation of qi, securing essence, reducing urination, restoring the pulse and relieving desertion, has a remarkable curative effect on the non-consolidation of kidney-qi and is reliable in action.
Description
Technical field
The present invention relates to a kind of pharmaceutical product of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of instability of kidney QI.
Background technology
Instability of kidney QI claims again instability of kidney-QI, refers to kidney qi virtual loss, the disease due to astringency inducing malfunction.Due to deficiency of kidney-QI, dysfunction of the kidney in storing essence, rushes admittedly, and occurs various symptoms.Clinical manifestation: soreness of the waist and knees, spiritlessness and weakness, tinnitus is become deaf, frequent micturition and clear, night, more so or dribble of urine was not to the utmost, or the enuresis, or urinary incontinence.Man's spermatorrhea, premature ejaculation; Not to the utmost, or leukorrhagia is clear rare and many for woman's menostaxis, or the easy edge of fetal movement.At present, the medicine for the treatment of instability of kidney QI on market is varied, thinks of but exist the length course for the treatment of, curative effect to pay no attention to the deficiency that side effect is large.
Motherland's medical science thinks, instability of kidney QI is many because year is high or natural endowment is not enough, or prolonged illness, chamber strain and cause in kidney due to vigour virtual loss.
According to theory of Chinese medical science, for the pathogeny of instability of kidney QI, employing is tonified Qi of the kidney, the method for the treatment of of controlling nocturnal emission with astringent drugs reducing urination, carries out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
The medicine for the treatment of instability of kidney QI in order to overcome in prior art exists the course for the treatment of long, curative effect to pay no attention to and think of the deficiency that side effect is large, the invention provides a kind of prepare easy, cost is low, the Chinese medicine composition of evident in efficacy, the treatment instability of kidney QI that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of instability of kidney QI, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Dioscoreae 5-25 part, Rhizoma Curcumae Longae 5-20 part, Pericarpium Citri Reticulatae 5-25 part, Radix Ginseng 5-20 part, Radix Angelicae Sinensis 5-25 part, Rhizoma Coptidis 5-20 part, Radix Codonopsis 5-25 part, Semen Alpiniae Katsumadai 5-20 part, Fructus Rubi 5-25 part, Fructus Amomi 5-20 part, Fructus Rosae Laevigatae 5-25 part, Rhizoma Chuanxiong 5-20 part, Semen Euryales 5-25 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Cyperi 5-25 part, Rhizoma Dioscoreae Septemlobae 10-30 part, Poria 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of instability of kidney QI, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Dioscoreaes, 10 parts, Rhizoma Curcumae Longae, 15 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Ginsengs, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Coptidis, 15 parts of Radix Codonopsis, 10 parts of Semen Alpiniae Katsumadai, 15 parts of Fructus Rubies, 10 parts of Fructus Amomis, 15 parts of Fructus Rosae Laevigatae, 10 parts of Rhizoma Chuanxiongs, 15 parts of Semen Euryaless, 25 parts of Radix Salviae Miltiorrhizaes, 15 parts of Rhizoma Cyperis, 20 parts of Rhizoma Dioscoreae Septemlobae, 15 parts of Poria, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: the Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Rhizoma Dioscoreae has strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, grow that will is calmed the nerves, effect of life lengthening; Rhizoma Curcumae Longae has effect of removing blood stasis circulation of qi promoting, inducing menstruation to relieve menalgia; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Radix Ginseng has that strongly invigorating primordial QI, multiple arteries and veins are admittedly de-, effect of invigorating the spleen to benefit the lung; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; Rhizoma Coptidis has effect of heat clearing and damp drying, eliminating fire and detoxication; Radix Codonopsis has effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Semen Alpiniae Katsumadai has warming spleen and stomach for dispelling cold, promoting the circulation of QI to relieve pain, drying damp and strengthening spleen effect; Fructus Rubi has effect of the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, supporing yang improving eyesight; Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Fructus Rosae Laevigatae has effect of controlling nocturnal emission with astringent drugs reducing urination, relieving diarrhea with astringents; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Semen Euryales has effect of supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, damp eliminating leukorrhagia stopping; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Cyperi has effect of liver-smoothing, qi-regulating, resolving depression pain relieving; Rhizoma Dioscoreae Septemlobae has dampness removing and goes turbid, to dispel the wind blood stasis dispelling effect; Poria has benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels effect damp and hot, row water stopping leak; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, helps using mutual assistant, play altogether tonify Qi of the kidney, controlling nocturnal emission with astringent drugs reducing urination, multiple arteries and veins are admittedly de-, effect of nourshing blood and promoting blood circulation, and the treatment of instability of kidney QI is reached to treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 92.2%, cure rate 68.9%.
The specific embodiment
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for instability of kidney QI, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Dioscoreae 15g, Rhizoma Curcumae Longae 10g, Pericarpium Citri Reticulatae 15g, Radix Ginseng 10g, Radix Angelicae Sinensis 15g, Rhizoma Coptidis 10g, Radix Codonopsis 15g, Semen Alpiniae Katsumadai 10g, Fructus Rubi 15g, Fructus Amomi 10g, Fructus Rosae Laevigatae 15g, Rhizoma Chuanxiong 10g, Semen Euryales 15g, Radix Salviae Miltiorrhizae 25g, Rhizoma Cyperi 15g, Rhizoma Dioscoreae Septemlobae 20g, Poria 15g, Radix Glycyrrhizae 10g.
Embodiment 2
Treat a Chinese medicine composition for instability of kidney QI, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Dioscoreae 25g, Rhizoma Curcumae Longae 5g, Pericarpium Citri Reticulatae 20g, Radix Ginseng 12g, Radix Angelicae Sinensis 25g, Rhizoma Coptidis 5g, Radix Codonopsis 25g, Semen Alpiniae Katsumadai 12g, Fructus Rubi 20g, Fructus Amomi 5g, Fructus Rosae Laevigatae 20g, Rhizoma Chuanxiong 12g, Semen Euryales 25g, Radix Salviae Miltiorrhizae 10g, Rhizoma Cyperi 20g, Rhizoma Dioscoreae Septemlobae 15g, Poria 25g, Radix Glycyrrhizae 12g.
Embodiment 3
Treat a Chinese medicine composition for instability of kidney QI, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 25g, Rhizoma Dioscoreae 10g, Rhizoma Curcumae Longae 15g, Pericarpium Citri Reticulatae 25g, Radix Ginseng 5g, Radix Angelicae Sinensis 20g, Rhizoma Coptidis 12g, Radix Codonopsis 20g, Semen Alpiniae Katsumadai 5g, Fructus Rubi 10g, Fructus Amomi 20g, Fructus Rosae Laevigatae 5g, Rhizoma Chuanxiong 15g, Semen Euryales 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Cyperi 5g, Rhizoma Dioscoreae Septemlobae 25g, Poria 10g, Radix Glycyrrhizae 8g.
Embodiment 4
Treat a Chinese medicine composition for instability of kidney QI, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Dioscoreae 20g, Rhizoma Curcumae Longae 12g, Pericarpium Citri Reticulatae 5g, Radix Ginseng 15g, Radix Angelicae Sinensis 10g, Rhizoma Coptidis 15g, Radix Codonopsis 5g, Semen Alpiniae Katsumadai 20g, Fructus Rubi 5g, Fructus Amomi 15g, Fructus Rosae Laevigatae 10g, Rhizoma Chuanxiong 20g, Semen Euryales 5g, Radix Salviae Miltiorrhizae 10g, Rhizoma Cyperi 25g, Rhizoma Dioscoreae Septemlobae 10g, Poria 20g, Radix Glycyrrhizae 5g.
Embodiment 5
Treat a Chinese medicine composition for instability of kidney QI, its raw material of Chinese medicine and weight proportion are: Rhizoma Atractylodis Macrocephalae 30g, Rhizoma Dioscoreae 5g, Rhizoma Curcumae Longae 20g, Pericarpium Citri Reticulatae 10g, Radix Ginseng 20g, Radix Angelicae Sinensis 5g, Rhizoma Coptidis 20g, Radix Codonopsis 10g, Semen Alpiniae Katsumadai 15g, Fructus Rubi 25g, Fructus Amomi 12g, Fructus Rosae Laevigatae 25g, Rhizoma Chuanxiong 5g, Semen Euryales 20g, Radix Salviae Miltiorrhizae 40g, Rhizoma Cyperi 10g, Rhizoma Dioscoreae Septemlobae 30g, Poria 5g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 6 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, after boiling with slow fire boiling 20～30 minutes; Decoct for the second time, add water and do not have approximately 4 centimetres of powder, after water boils, decoct 15～20 minutes.Decoct extracting juice twice, merge.
The present invention, with the given a kind of Chinese medicine composition for the treatment of instability of kidney QI of embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 90 examples, male 54 examples, female's 36 examples, 20～55 years old age.
Two, diagnosis basis:
According to its clinical showed primary symptom, inferior disease, and make diagnosis in conjunction with tongue arteries and veins:
1, primary symptom: frequent micturition number and clear, dribble of urine not to the utmost, the enuresis or incontinence, spermatorrhea premature ejaculation, fetal movement is easily sliding;
2, inferior disease: pale complexion, spiritlessness and weakness, soreness of the waist and knees, auditory dysesthesia, spontaneous perspiration, clear and thin leucorrhea;
3, tongue arteries and veins: pale tongue with white fur, thready and weak pulse;
Possess 1 person in above-listed condition, can be diagnosed as assertive evidence.
Three, usage and dosage: when clinical practice, potion on the one, the about 400ml of twice extracting juice of decocting, point morning, late twice decoction being taken warmly.It within six days, is a course for the treatment of.
Four, criterion of therapeutical effect:
(1) recovery from illness: symptom and sign disappears, does not recur after stopping using;
(2) effective: symptom is obviously alleviated, simultaneous phenomenon disappears substantially or large portion alleviates;
(3) effective: in high spirits and simultaneous phenomenon alleviates, increase the weight of but meet influence factor;
(4) invalid: all symptoms increase the weight of trend without alleviating or having.
Five, therapeutic effect: in this clinical observation case, take medicine 2-8 the course for the treatment of, recovery from illness 62 examples, follow up a case by regular visits to and have no recurrence; Effective 12 examples, effective 9 examples, invalid 7 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Bao, man, 36 years old.Before two weeks, there is frequent micturition number and clear, dribble of urine not to the utmost, the enuresis, spermatorrhea premature ejaculation, and with soreness of the waist and knees, auditory dysesthesia, the symptoms such as spontaneous perspiration.Examine and see: pale tongue with white fur, thready and weak pulse.Be diagnosed as: instability of kidney QI.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, frequent micturition number of times obviously reduces, and all the other symptoms are also eased; Continue to take 2 courses for the treatment of, all diseases disappear, recovery from illness.After half a year, follow up a case by regular visits to without recurrence.
Case 2:
Poplar, female, 42 years old.Before one, occur frequent micturition and clear, night, more so not to the utmost, menostaxis not to the utmost, and had spiritlessness and weakness concurrently to dribble of urine, the tinnitus disease such as become deaf.Diagnosis: instability of kidney QI.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, urine number of times reduces, and all the other symptoms alleviate.Continue to take 2 courses for the treatment of, urine number of times and menstruation recovery are normal, other transference cures, recovery from illness.After 1 year, follow up a case by regular visits to without recurrence.
Claims (2)
1. a Chinese medicine composition for the treatment of instability of kidney QI, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Rhizoma Atractylodis Macrocephalae 10-30 part, Rhizoma Dioscoreae 5-25 part, Rhizoma Curcumae Longae 5-20 part, Pericarpium Citri Reticulatae 5-25 part, Radix Ginseng 5-20 part, Radix Angelicae Sinensis 5-25 part, Rhizoma Coptidis 5-20 part, Radix Codonopsis 5-25 part, Semen Alpiniae Katsumadai 5-20 part, Fructus Rubi 5-25 part, Fructus Amomi 5-20 part, Fructus Rosae Laevigatae 5-25 part, Rhizoma Chuanxiong 5-20 part, Semen Euryales 5-25 part, Radix Salviae Miltiorrhizae 10-40 part, Rhizoma Cyperi 5-25 part, Rhizoma Dioscoreae Septemlobae 10-30 part, Poria 5-25 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of instability of kidney QI according to claim 1, is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Rhizoma Dioscoreaes, 10 parts, Rhizoma Curcumae Longae, 15 parts of Pericarpium Citri Reticulataes, 10 parts of Radix Ginsengs, 15 parts of Radix Angelicae Sinensis, 10 parts of Rhizoma Coptidis, 15 parts of Radix Codonopsis, 10 parts of Semen Alpiniae Katsumadai, 15 parts of Fructus Rubies, 10 parts of Fructus Amomis, 15 parts of Fructus Rosae Laevigatae, 10 parts of Rhizoma Chuanxiongs, 15 parts of Semen Euryaless, 25 parts of Radix Salviae Miltiorrhizaes, 15 parts of Rhizoma Cyperis, 20 parts of Rhizoma Dioscoreae Septemlobae, 15 parts of Poria, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410107019.6A CN103816493B (en) | 2014-03-21 | 2014-03-21 | A kind of Chinese medicine composition treating instability of kidney QI |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410107019.6A CN103816493B (en) | 2014-03-21 | 2014-03-21 | A kind of Chinese medicine composition treating instability of kidney QI |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103816493A true CN103816493A (en) | 2014-05-28 |
| CN103816493B CN103816493B (en) | 2016-10-05 |
Family
ID=50751973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410107019.6A Expired - Fee Related CN103816493B (en) | 2014-03-21 | 2014-03-21 | A kind of Chinese medicine composition treating instability of kidney QI |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103816493B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107582978A (en) * | 2017-10-19 | 2018-01-16 | 成都兴倍加生物科技有限责任公司 | It is a kind of effectively to treat decoction medicine of the unconsolidation of the kidney-qi and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62198621A (en) * | 1986-02-24 | 1987-09-02 | Kanebo Ltd | Carcinostatic assistant |
| CN1363307A (en) * | 2001-01-10 | 2002-08-14 | 杨孟君 | Nano medicine 'Guiluningshen' and its preparing process |
| CN1480204A (en) * | 2003-08-05 | 2004-03-10 | 刘顺礼 | Preparation of Chinese herbal medicine for treating barrenness of women |
-
2014
- 2014-03-21 CN CN201410107019.6A patent/CN103816493B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62198621A (en) * | 1986-02-24 | 1987-09-02 | Kanebo Ltd | Carcinostatic assistant |
| CN1363307A (en) * | 2001-01-10 | 2002-08-14 | 杨孟君 | Nano medicine 'Guiluningshen' and its preparing process |
| CN1480204A (en) * | 2003-08-05 | 2004-03-10 | 刘顺礼 | Preparation of Chinese herbal medicine for treating barrenness of women |
Non-Patent Citations (3)
| Title |
|---|
| 何志军等: "环孢素A联合激素和中药治疗膜性肾病疗效分析", 《中国中西医结合肾病杂志》 * |
| 尹国有等: "《中医内科经典验案300例点评》", 31 October 2011, article "肾气不固所致之遗精" * |
| 尹国有等: "《中医内科经典验案300例点评》", 31 October 2011, 军事医学科学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107582978A (en) * | 2017-10-19 | 2018-01-16 | 成都兴倍加生物科技有限责任公司 | It is a kind of effectively to treat decoction medicine of the unconsolidation of the kidney-qi and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103816493B (en) | 2016-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103463404B (en) | Traditional Chinese medicine composition for treating liver and kidney yin deficiency | |
| CN103463528A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN103463587A (en) | Traditional Chinese medicine composition for treating deficiency-cold in spleen and stomach | |
| CN102988672B (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN103028090B (en) | Traditional Chinese medicine composition for treating Qi deficiency | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
| CN103550661A (en) | Chinese medicinal composition for treating stomach cold and stomachache | |
| CN103394030B (en) | Traditional Chinese medicine composition for treating depressed liver and deficient spleen | |
| CN103028089B (en) | Traditional Chinese medicine composition for treating waist pains of middle-aged and old people | |
| CN103816337A (en) | Traditional Chinese medicinal composition for treating delayed menstrual cycle | |
| CN103816527A (en) | Traditional Chinese medicinal composition for treating heart-yang deficiency | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN103721237A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN104758826A (en) | Traditional Chinese medicine composition for treating abdominal distension | |
| CN103816403A (en) | Chinese medicinal composition for treating syndrome of deficiency of liver blood | |
| CN103800881A (en) | Traditional Chinese medicine composition for treating heart-spleen deficiency syndrome | |
| CN103816469A (en) | Chinese medicinal composition for treating deficiency of spleen and kidneys | |
| CN103816470A (en) | Traditional Chinese medicine composition for treating anorexia | |
| CN103690925A (en) | Traditional Chinese medicinal composition for treating amenorrhea | |
| CN103800833A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Liu Chunfeng Inventor after: Wang Jianrong Inventor after: Zou Jibao Inventor before: Wang Jianrong Inventor before: Zou Jibao |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160906 Address after: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 Applicant after: Liu Chunfeng Address before: 264300 Shandong city of Weihai province Rongcheng Chengshan Avenue East No. 101 Applicant before: Wang Jianrong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20161005 Termination date: 20170321 |